fbpx Skip to main content

Member's Profile

Hawaii Biotech, Inc.

Location
650 Iwilei Road
Honololu,   HI
96817
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2020
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Hawaii Biotech, Inc.
Biotech Company
Hawaii Biotech (HBI) is a privately held biotechnology company focused on the development of prophylactic vaccines for established and emerging infectious diseases and anti-toxin drugs for biological threats. HBI has developed proprietary expertise in the production of recombinant proteins that have application to the manufacture of safe and effective vaccines, diagnostic kits, and as research tools. HBI completed successful first-in-human Phase 1 clinical studies with both West Nile virus and dengue vaccines in healthy human subjects. HBI has developed a product pipeline of recombinant subunit vaccines, including vaccine candidates for West Nile virus, tick-borne flavivirus, malaria, Crimean-Congo hemorrhagic fever, and Ebola. The company is also continuing the development of small molecule anti-toxin drugs for anthrax and botulism. HBI, founded in Hawaii in 1982, is headquartered in Honolulu.
Related News
No related news posted by this Member